Mealey's (March 19, 2019, 12:15 PM EDT) -- WASHINGTON, D.C. — In a March 14 decision, the Federal Circuit U.S. Court of Appeals directed a Delaware federal judge to reconsider the question of whether a patent covering the antipsychotic drug Saphris is infringed by a proposed generic (Forest Laboratories LLC v. Sigmapharm Laboratories LLC, et al., No. 17-2369, Fed. Cir.)....